Delivery Order SPE2DE24DA010-SPE2D626F07PU
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $28,350 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment is scheduled for completion by January 20, 2026, and will be performed in Santa Clara, California. The delivery order carries no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $28,350 from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. The contract utilizes a fixed-price structure with economic price adjustment provisions and carries no set-aside designation, reflecting full and open competition. Performance will take place in Santa Clara, California, where Abbott maintains...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $39,422.80 fixed-price delivery order (Contract 4570007649, GALLANT) by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with completion scheduled for November 19, 2025. This delivery order, which carries no set-aside designation, represents a task order issued against Abbott's broader $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 17, 2025. This delivery order, issued without a small business set-aside designation, represents a task order against Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $11,750 on November 4, 2025, by the Defense Logistics Agency's Medical Supply Chain for cardiovascular medical devices and related technologies. The contract, which is not set-aside and operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 7, 2025, with performance taking place in Santa Clara, California. This delivery...
- Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a delivery order award valued at $8,901.70 from the Defense Logistics Agency's Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 10, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation and is for performance in Santa Clara, California. The delivery order represents a task order against Abbott Vascular's larger Indefinite Delivery Contract with the...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F07PUDelivery Order
Abbott Laboratories Inc.'s Abbott Vascular Inc. division received a $28,350 fixed-price delivery order (4570509248) from the Defense Logistics Agency's Medical Supply Chain on January 7, 2026, with an ultimate completion date of January 20, 2026. This delivery order was awarded without a set-aside designation through full and open competition and will be performed in Santa Clara, California. The award represents a task order under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense Logistics Agency for comprehensive cardiovascular procedural packages that include devices, instrumentation, accessories, and related medical technologies supporting complex surgical procedures across the federal healthcare system. Abbott Vascular serves as a strategic supplier of advanced cardiovascular medical technologies to federal healthcare agencies, with a substantial contract portfolio focused on stents, pacemakers, heart valves, implantable cardiac monitors, left ventricular assist devices, and transcatheter valve repair systems. The company has demonstrated consistent success in federal competitive procurements, maintaining numerous IDCs across Veterans Integrated Service Networks and the Defense Health Agency, positioning it as an essential element of the federal government's medical supply infrastructure for supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.4k | 1/6/26 |